Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys

Psychopharmacology

Volumn 124, Issue 1-2, 1996, Pages 134-140

  Casey, Daniel E ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Clozapine; Dopamine; Extrapyramidal side effects; Haloperidol; Neurleptics; Nonhuman primates; Risperidone; SErotonin; Sertindole

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; SERTINDOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CEBIDAE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; MONKEY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SEDATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CEBUS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; IMIDAZOLES; INDOLES; RISPERIDONE;

EID: 0029991892     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02245613     Document Type: Article

References (25)

1. Casey DE (1989a) Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates. Psychopharmacol Bull 25: 457-459
2. Casey DE (1989b) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 99: S47-S53
3. Casey DE (1993) Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates. Psychopharmacology 112: S55-S59
4. Casey DE (1994) Motor and mental aspects of acute extrapyramidal syndromes. Acta Psychiatr Scand 89: 14-20
5. 2 and serotonin mechanisms. Proc. Alfred Benzon Symposium 38. In: Fog R, Gerlach J, Hemmingsen R (eds) Schizophrenia: an integrated view. Munksgaard Press, Copenhagen, pp 287-297
6. Casey DE, Hansen TE (1995) Schizophrenia psychopharmacology: risperidone and clozapine. In: Jefferson JW, Griest JH (eds) The psychiatric clinics of North America: annual of drug therapy. W.B. Saunders, Philadelphia, pp 119-149
7. Cohen BM, Keck PE, Satlin A et al. (1991) Prevalence and severity of akathisia in patients on clozapine. Biol Psychiatry 29: 1215-1219
8. Fink-Jensen A, Kristensen P (1994) Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neurosci Lett 182: 115-118
9. 1 receptors (ex vivo radioreceptor binding studies). J Neural Transm 89: 61-69
10. Jackson DM, Johansson C, Lindgren L et al. (1994) Dopamine receptor antagonism block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol Biochem Behav 48:465-471
11. Kane JM, Honigfeld G, Singer J et al. (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789-796
12. Kurz M, Hummer M, Oberbauer H et al. (1995) Extrapyramidal side effects of clozapine and haloperidol. Psychopharmacology 118[1]: 52-56
13. Lieberman JA, Saltz BL, Johns CA et al. (1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158: 503-510
14. Liebman J, Neale R (1980) Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Psychopharmacology 68: 25-29
15. Marder SR, Meibach RC (1994) Risperidone in the treatment of schizophrenia. Am J Psychiatry 151[6]: 825-835
16. Martin PT, Grebb JA, Schmitz PJ et al. (1994) Efficacy and safety of sertindole in double-blind, placebo-controlled trials of schizophrenia patients. Schizophr Res 11: 107
17. i values. J Pharmacol Exp Ther 251: 238-246
18. Peacock L, Solgaard T, Lublin H, Gerlach J (1996) Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects. Psychopharmacology 124: 188-196
19. 2 antagonists within a series of 3-substituted 1-(4-flourophenyl)-1H-indoles. J Med Chem 35: 1092-1101
20. Peuskens J (1995) Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Br J Psychiatry 166:712-726
21. Saltz BL, Woerner M, Kane JM et al. (1991) Prospective study of tardive dyskinesia incidence in the elderly. JAMA 266: 2402-2406
22. Sanchez C, Arnt J, Dragsted N et al. (1991) Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Dev Res 22: 239-250
23. Sanger DJ, Perrault G (1995) Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats. J Pharmacol Exp Ther 272: 708-713
24. Skarsfeldt T (1992) Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurons in rats: acute and repeated treatment. Synapse 10: 25-33
25. Van Kammen DP, McEvoy JP, Targum SD, Kardatzke D, Sebree TB, Sertindole Study Group (1996) A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. Psychopharmacology 124: 168-175